Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-24 @ 10:18 PM
NCT ID:
NCT01167335
Brief Summary:
This study will assess the efficacy of BGG492 as adjunctive treatment in patients with refractory partial onset seizures
Study:
NCT01167335
Study Brief:
Protocol Section:
NCT01167335